Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

High content screening of patient-derived cell lines highlights the potential of non-standard chemotherapeutic agents for the treatment of glioblastoma

Table 1

Patient demographics, clinical features and cell line designations.

Table 1

doi: https://doi.org/10.1371/journal.pone.0193694.t001